303 related articles for article (PubMed ID: 27633613)
1. Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.
Céspedes-Garro C; Naranjo MG; Rodrigues-Soares F; LLerena A; Duconge J; Montané-Jaime LK; Roblejo H; Fariñas H; Campos ML; Ramírez R; Serrano V; Villagrán CI; Peñas-LLedó EM
Pharmacogenomics; 2016 Oct; 17(15):1707-1724. PubMed ID: 27633613
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics in Central American healthy volunteers: interethnic variability.
Céspedes-Garro C; Naranjo ME; Ramírez R; Serrano V; Fariñas H; Barrantes R; LLerena A;
Drug Metab Pers Ther; 2015 Mar; 30(1):19-31. PubMed ID: 25490028
[TBL] [Abstract][Full Text] [Related]
3. Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics).
Fricke-Galindo I; Jung-Cook H; LLerena A; López-López M
Drug Metab Pers Ther; 2016 Jun; 31(2):61-81. PubMed ID: 26812836
[TBL] [Abstract][Full Text] [Related]
4. The frequency of HLA-B(∗)57:01 and the risk of abacavir hypersensitivity reactions in the majority population of Costa Rica.
Arrieta-Bolaños E; Madrigal JA; Marsh SG; Shaw BE; Salazar-Sánchez L
Hum Immunol; 2014 Nov; 75(11):1092-6. PubMed ID: 25286002
[TBL] [Abstract][Full Text] [Related]
5. Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.
Bousman CA; Jaksa P; Pantelis C
Pharmacogenet Genomics; 2017 Nov; 27(11):387-393. PubMed ID: 28777243
[TBL] [Abstract][Full Text] [Related]
6. An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean.
Salas-Hernández A; Galleguillos M; Carrasco M; López-Cortés A; Redal MA; Fonseca-Mendoza D; Esperón P; González-Martínez F; Lares-Asseff I; Lazarowski A; Loera-Castañeda V; Remírez D; Martínez MF; Vargas R; Rios-Santos F; Macho A; Cayún JP; Perez GR; Gutierrez C; Cerpa LC; Leiva T; Calfunao S; Xajil L; Sandoval C; Suárez M; Gonzalez A; Echeverría-Garcés G; Sullón-Dextre L; Cordero-García E; Morales AR; Avendaño A; Sánchez E; Bastone LC; Lara C; Zuluaga-Arias P; Soler AM; Da Luz J; Burgueño-Rodríguez G; Vital M; Reyes-Reyes E; Huaccha A; Ariza YV; Tzul N; Rendón AL; Serrano R; Acosta L; Motta-Pardo A; Beltrán-Angarita L; Brand E; Jiménez MA; Hidalgo-Lozada GM; Romero-Prado MMJ; Escobar-Castro K; Umaña-Rivas M; Vivas JD; Lagos P; Martínez YB; Quesada S; Calfio C; Arias ML; Lavanderos MA; Cáceres DD; Salazar-Granara A; Varela NM; Quiñones LA
Front Pharmacol; 2023; 14():1175737. PubMed ID: 37251329
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics research in Brazil: a systematic review.
Torres-Loureiro S; Scudeler MM; Andrade PX; Sampaio-Coelho J; Nobre IH; Céspedes-Garro C; Tarazona-Santos E; Llerena A; Rodrigues-Soares F
Pharmacogenomics; 2022 Mar; 23(4):263-275. PubMed ID: 35187980
[No Abstract] [Full Text] [Related]
8. Pharmacogenetics of antiretrovirals.
Tozzi V
Antiviral Res; 2010 Jan; 85(1):190-200. PubMed ID: 19744523
[TBL] [Abstract][Full Text] [Related]
9. Mixtec Mexican Amerindians: an HLA alleles study for America peopling, pharmacogenomics and transplantation.
Arnaiz-Villena A; Vargas-Alarcón G; Areces C; Enríquez-de-Salamanca M; Abd-El-Fatah-Khalil S; Fernández-Honrado M; Marco J; Martín-Villa JM; Rey D
Immunol Invest; 2014; 43(8):738-55. PubMed ID: 25254939
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health.
Zhou Y; Lauschke VM
Hum Genet; 2022 Jun; 141(6):1113-1136. PubMed ID: 34652573
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic biomarkers as tools for improved drug therapy; emphasis on the cytochrome P450 system.
Ingelman-Sundberg M; Sim SC
Biochem Biophys Res Commun; 2010 May; 396(1):90-4. PubMed ID: 20494117
[TBL] [Abstract][Full Text] [Related]
12. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
de Leon J; Susce MT; Murray-Carmichael E
Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
Kirchheiner J; Seeringer A
Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
[TBL] [Abstract][Full Text] [Related]
14. Personalized pharmacotherapy in psychiatry.
Filaković P; Petek A
Psychiatr Danub; 2009 Sep; 21(3):341-6. PubMed ID: 19794353
[TBL] [Abstract][Full Text] [Related]
15. Lessons from Cuba for Global Precision Medicine: CYP2D6 Genotype Is Not a Robust Predictor of CYP2D6 Ultrarapid Metabolism.
Dorado P; González I; Naranjo ME; de Andrés F; Peñas-Lledó EM; Calzadilla LR; LLerena A
OMICS; 2017 Jan; 21(1):17-26. PubMed ID: 28271978
[TBL] [Abstract][Full Text] [Related]
16. CYP2D6 and pharmacogenomics: where does future research need to focus? Part 2: clinical aspects.
Leeder JS; Gaedigk A
Pharmacogenomics; 2014 Jun; 15(8):1055-8. PubMed ID: 25084197
[No Abstract] [Full Text] [Related]
17. Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America.
Sosa-Macías M; Teran E; Waters W; Fors MM; Altamirano C; Jung-Cook H; Galaviz-Hernández C; López-López M; Remírez D; Moya GE; Hernández F; Fariñas H; Ramírez R; Céspedes-Garro C; Tarazona-Santos E; LLerena A
Pharmacogenomics; 2016 Nov; 17(16):1741-1747. PubMed ID: 27790935
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.
Quaranta S; Dupouey J; Colle R; Verstuyft C
Therapie; 2017 Apr; 72(2):311-318. PubMed ID: 28237405
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of healthy volunteers in Puerto Rico.
Claudio-Campos K; Orengo-Mercado C; Renta JY; Peguero M; García R; Hernández G; Corey S; Cadilla CL; Duconge J
Drug Metab Pers Ther; 2015 Dec; 30(4):239-49. PubMed ID: 26501165
[TBL] [Abstract][Full Text] [Related]
20. Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines?
Fan M; Bousman CA
Pharmacopsychiatry; 2020 Jul; 53(4):174-178. PubMed ID: 30900236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
